Hospira, Inc., Issues A Voluntary Nationwide Recall for one lot of BACTERIOSTATIC WATER for Injection, USP, due to a Potential Lack of Sterility Assurance Hospira, Inc., a Pfizer company, is voluntarily recalling BACTERIOSTATIC WATER for Injection, USP, 30 mL, multi-dose vial, lot W20308, to the Hospital/Retail level
5002,000 mcg once daily, titrated upward gradually across a 12-week example course
Systemic lupus erythematosus (SLE) and rheumatoid arthritis have been noted in case reports
Progress photos every two weeks in consistent lighting, clothing, and positioning
Retention strategies like coaching calls, injection reminders, and motivational interviews kept dropout rates low
Women should check local leisure centres, children's centres, and council websites for available activities in their area